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WOMAC
EQ-5D
Knee Society ScoreOur study aimed at developing clinical thresholds (cut-off scores) for theWestern Ontario andMcMaster Univer-
sities (WOMAC) osteoarthritis index, EQ-5D and Knee Society Score for discriminating between patients with
and without treatment success following total knee arthroplasty (TKA). We performed a retrospective analysis
of 1055 patients 2 months after TKA and 765 patients 1 year after TKA. We considered treatment successful if
the patient reported high levels of satisfaction and pain relief, functional increase, and a willingness to undergo
the same procedure again. Based on this criterion we identified cut-off scores that will facilitate interpretation
of the WOMAC, the EQ-5D and the KSS in TKA patients.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Patient-reported outcome (PRO) measures have become a corner-
stone of outcome assessment after joint surgery. A range of validated
questionnaires are available for assessing joint-specific parameters
(e.g. function, pain) [1–6] and general health outcomes (e.g. quality
of life) [7,8]. This extension of outcome assessment reflects the fact
that parameters such as any-cause-revision rate are not sufficient
to provide the full picture of outcome of joint surgery. An increasing
number of total knee arthroplasty (TKA) registries have therefore
been supplemented with PRO measures to capture function, pain or
patient satisfaction [9–12].
However, whereas an increasing number of outcomeparameters are
being assessed, a generic definition of treatment success after TKA is
lacking. Because TKA is elective surgery, in recent years, patient satisfac-
tion has gained interest as a single overarching outcome parameter
[13–15]. However, it is well known that patient satisfaction is in-
fluenced substantially by factors not directly related to TKA, such as
patient's mental status [16], hospital experience [17], cultural back-
ground [18], socioeconomic status [19] and body mass index [20].
Whereas patient satisfaction is definitely a key parameter of outcomedpotential or pertinent conflicts
direct or indirect, institutional
eld which may be perceived to
l disclosure statements refer to
, Department of Orthopaedics
hacherstrasse 95, St. Gallen
. This is an open access article underassessment after TKA, relying solely on this constructmaynot be sufficient
for comprehensive treatment evaluation.
Previous attempts to define treatment success on the basis of PRO
scores mostly focused on change rates, comparing pre-surgical scores
with follow-up assessments, and investigated minimal important dif-
ferences for commonly used PRO instruments to identify patients with
and without treatment success [21–24].
However, relying only on change rates ignores the fact that patients
can experience substantial improvement following surgery but still
have relevant functional impairments or pain, which would suggest
the inappropriateness of classifying the treatment as successful [25].
To guide interpretation of absolute scores, two methodological
approaches are generally applicable: A distribution-based approach re-
lates individual PRO scores or groupmeans to reference data, e.g., score
distributions in a general population. This allows for evaluation of the
extent to which a patient recovers to ‘normal’ levels post-surgery (e.g.
with regard to function or pain). Relating scores to reference popula-
tions does not per se provide thresholds for treatment success, but cer-
tainly improves interpretability of PRO scores. In contrast, anchor-based
approaches relate PRO scores to external criteria for treatment success
and allow identification of thresholds (i.e. cut-off values) for PRO
measures that reflect these criteria. In an anchor-based approach, the
definition of the external criterion is crucial.
In our study, we employed a rather comprehensive definition of
treatment success comprising patient satisfaction, functional improve-
ment, pain relief, and willingness to undergo the same procedure
again. On the basis of this conceptualization of treatment success, wethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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used in the orthopedic field: the joint-specific Western Ontario and
McMaster Universities (WOMAC) osteoarthritis index [1] and the ge-
neric EQ-5D questionnaire [7]. In addition, we determined treatment
success thresholds for the Knee Society Score (KSS), a hybrid measure
including patient-reported and clinician-rated outcomes [3].
Patients and Methods
Sample
Our retrospective analysis was based on data available from the local
TKA registry at the Kantonsspital St. Gallen (Switzerland). Consecutive
patients from February 2006 to December 2013 that underwent primary
TKAandprovided PROquestionnaires at 2- or 12-month follow-upwere
included in the study. All knee arthroplasties were LCS complete (Low
Contact Stress Knee System DePuy) knee protheses (rotating platform).
Patients undergoing revision surgery within 12 months after primary
TKA were excluded from the analysis (n = 9). All patients included in
our registry provide written informed consent for anonymized data
analysis. Approval for registry data analysis was obtained from the
local ethics committee.
Outcome Measures
Definition of Treatment Success
As an external criterion for defining thresholds for the PRO
measures, we used a combination of the following anchor questions:
• How satisfied are you with your knee arthroplasty?
(very highly or highly satisfied vs. moderately, minimally or not at
all satisfied)
• If you had the choice, would you undergo the procedure again
under the same conditions?
(yes vs. no)
• Did the surgery increase your functional capacity?
(yes vs. no)
• Did the surgery relief your pain?
(yes vs. no)
We considered TKA successful only if the patient fulfilled all four
criteria, i.e., if the patient reported pain relief, functional improvement,
high or very high satisfaction, and willingness to have TKA surgery
again. This strict definition allowed creation of a dichotomous external
criterion for receiver operator characteristic (ROC) analysis to determine
treatment success thresholds for the WOMAC, the KSS and the EQ-5D.
WOMAC
The WOMAC Osteoarthritis Index developed by Bellamy et al [1] is
one of the most commonly used, patient-reported outcome measures
in patients with lower limb osteoarthritis. The questionnaire contains
24 items covering three dimensions: pain (5 items), stiffness (2
items), and function (17 items). TheWOMAChas been extensively tested
for validity, reliability, feasibility, and responsiveness to change over time
[1,26–28]. The WOMAC scores can be linearly transformed to a 0–100
scale, with higher scores indicating more severe impairment.
EQ-5D
The EQ-5D-3L is a generic five-item questionnaire for the assess-
ment of self-reported general health [7]. It is widely used in various
fields of medical research to collect quality-of-life scores as a basis for
determining health state utilities, which allow calculation of quality-
adjusted life-years [29].
Knee Society Score (KSS)
The Knee Society Score [3] is a widely used, clinician-reported out-
come score with good published validity data [30]. The clinician-ratedportion (Knee Score) of the KSS covers pain, range of movement, align-
ment, and stability. The patient-reported portion (Function Score) of the
KSS covers the patient's mobility (walking distance and stairs) and po-
tential walking aids. Score range of the KSS is from 0 to 100 points for
each portion, with higher scores indicating better outcome.
Statistical Analysis
Sample characteristics are given as means, standard deviations,
ranges, and frequencies.
Determination of thresholds was based on ROC analyses using the
outcome measures (WOMAC, EQ-5D, KSS) as predictors and the previ-
ously defined dichotomous variable ‘treatment success’ as the criterion.
In the ROC analysis, the area under the curve (AUC) is a measure of di-
agnostic accuracy, i.e., the ability of an outcome measure to predict the
criterion. An AUC of 0.50 equals chance, whereas 1.00 reflects perfectly
accurate prediction. In fact, the AUC gives the probability that a positive
case (patient with treatment success according to the external criteri-
on) has a higher PRO score than does a negative case (a patient without
treatment success). In linewithHosmer and Lemeshow [31], an AUC be-
tween 0.70 and 0.80 indicates acceptable discrimination and an AUC
above 0.80 indicates excellent discrimination.
We report cut-off values for an outcome measure as a threshold for
treatment success that provides the highest sensitivity and specificity
(i.e., the cut-off with the highest sum of sensitivity and specificity). For
purposes of comparison, we provide AUCs not only for the aggregated
external criterion as defined above, but also for individual components
of the criterion. Analysis was performed separately for 2- and 12-
month follow-up to provide thresholds for treatment success for both
time points and to investigate changes in cut-off values over time.
Results
Patient Characteristics
Analysis of treatment success 2 months post-surgery included 1055
cases (mean age: 68.8 years; 60.2% were female). Twelve months post-
surgery, 765 patients were eligible for analysis (mean age: 68.4 years;
61.4% female). The two samples did not differ significantly with regard
to age, sex, side of implant and body mass index (all P N 0.30).
WOMAC, EQ-5D and KSS scores were significantly different (all
P b 0.001) at 2- and 12-month follow-up, with the largest difference
found for the KSS Function Score (effect size: Cohen's d = 1.05) and
the smallest for the EQ-5D (d = 0.30). For further details see Table 1.
Treatment Success 2 and 12 Months Post-surgery
Satisfaction rates did not differ significantly between the two follow-
up time points, with 77.5% of patients being very highly or highly satis-
fied at 2 months and 76.8% at 12 months (P = 0.247). In line with this,
we found the same number of patients (89.6%) willing to undergo the
same surgery again (P = 0.402) at both follow-up time points. The
number of patients reporting improved function increased from 69.0%
at 2 months to 83.4% at 12 months (P b 0.001), and the number of pa-
tients reporting less pain after surgery increased from 84.7% to 91.2%
over the same period (P b 0.001, Table 1).
The combined (four-part) external criterionwasmet by 61.4% of pa-
tients at 2 months and by 70.6% at 12months (increase statistically sig-
nificant with P=0.001, Table 1). Correlations between the four parts of
the external criterion were between r= 0.41 and r=0.55 at 2 months
and between r = 0.48 and r = 0.55 at 12 months (all P b 0.001).
Thresholds for Treatment Success at 2- and 12-Month Follow-Up
The highest accuracy for predicting treatment success at 2 months
was found for the WOMAC Pain score (AUC = 0.76), the WOMAC
Table 1
Comparison of Sample Characteristics and Treatment Success Criteria at 2- and 12-Month
Follow-Up.
2 months
(n = 1055)
12 months
(n = 765)
P-Values
Age Mean (SD) 68.8 (9.4) 68.4 (9.4) 0.460
Range 25–92 25–92
Sex Women 60.2% 61.4% 0.593
Men 39.8% 38.6%
Side Left 47.0% 45.8% 0.601
Right 53.0% 54.2%
Body mass index Mean (SD) 29.1 (5.4) 29.4 (5.5) 0.332
Range 18–52 18–62
Treatment success criteria
Satisfaction 77.5% 76.8% 0.247
Surgery again 89.6% 89.6% 0.402
More activity 69.0% 83.4% b0.001
Less Pain 84.7% 91.2% b0.001
Total anchor 61.4% 70.6% 0.001
Scales, mean (SD)
WOMAC Pain 19.2 (16.7) 9.1 (15.0) b0.001
WOMAC Stiffness 27.2 (22.5) 15.4 (19.5) b0.001
WOMAC Function 25.3 (18.6) 14.7 (18.0) b0.001
WOMAC Total 24.1 (17.3) 13.6 (16.5) b0.001
EQ-5D 0.78 (0.22) 0.85 (0.21) b0.001
KSS Knee Score 68.7 (28.1) 78.1 (29.4) b0.001
KSS Function Score 46.4 (22.7) 70.1 (29.3) b0.001
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of ‘acceptable’ discrimination [31]. The lowest accuracy was observed
for the WOMAC Stiffness scale (AUC = 0.69) and the KSS Function
Score (AUC= 0.62).
Accuracy for predicting treatment success was mostly higher at 12-
month compared with 2-month follow-up. At 12 months, the WOMAC
Pain and the WOMAC Total scale performed best in discriminating pa-
tients with/without treatment success (both AUC = 0.83), followed by
WOMAC Function (AUC = 0.82). In contrast, the AUC of 0.77 for the
EQ-5D remained rather stable and did not reach the threshold for excel-
lent discrimination. The KSS Knee score performed comparably (AUC=
0.75), whereas the KSS Function Score (AUC = 0.69) again failed to
reach the threshold for acceptable discrimination. For further details,
see Table 2 and Fig. 1.
For all outcome measures with the exception of the EQ-5D, the cut-
off values moved from 2 months to 12 months toward better outcome.
Values for the EQ-5D remained stable (0.79 vs. 0.80 points). For the
WOMAC total score, the cut-off dropped from 29.5 points (sensitivity
0.80, specificity 0.57) at 2 months to 16.5 points at 12 months (sensiti-
vity 0.85, specificity 0.68). This change was also reflected in the
WOMAC's subscales. For the KSS, the change in cut-off values wasTable 2
Accuracy in Terms of Area Under the Curve (AUC) for theWOMAC, the EQ-5D and theKSS.
Time Point Total Anchor, AUC 95% Confidence interval
WOMAC Pain 2 months 0.76 0.72–0.79
12 months 0.83 0.79–0.86
WOMAC Stiffness 2 months 0.69 0.65–0.72
12 months 0.70 0.66–0.75
WOMAC Function 2 months 0.73 0.70–0.77
12 months 0.82 0.78–0.85
WOMAC Total 2 months 0.75 0.72–0.78
12 months 0.83 0.80–0.87
EQ-5D 2 months 0.75 0.72–0.78
12 months 0.77 0.73–0.81
KSS Knee Score 2 months 0.73 0.70–0.76
12 months 0.75 0.72–0.79
KSS Function Score 2 months 0.62 0.58–0.65
12 months 0.69 0.65–0.72smaller for the Knee score (75.5–85.5 points) than for the Function
score (42.5–72.5). Further details are given in Table 3.
Discussion
Our study provides thresholds for identifying treatment success
after TKA for commonly employed outcome measures. The develop-
ment of thresholds relied on a compound definition of patient-
reported treatment success that included satisfaction with surgical out-
come, willingness to undergo surgery again, pain relief and functional
improvement. Overall, the joint-specific WOMAC score was found to
be highly predictive for treatment success, especially at 12-month
follow-up, and it outperformed the EQ-5D and the KSS. Prediction of
treatment success was more accurate at 12-month compared with 2-
month follow-up (Table 2).
Thresholds for theWOMAC and the KSSwere time dependent, i.e., at
the later time point (12 months), better outcome was required to con-
stitute treatment success (Table 3). Interestingly, the answers to the
two anchor questions regarding satisfaction and willingness to have
surgery again were very stable at both time points (Table 1). This may
be explained by effective pre-operative patient education and good
management of patients’ expectations. Patients clearly had a higher
symptom burden after 2 months compared with 12 months (Table 1).
However, because they were told to expect this course, their rates of
satisfaction (about 77%) and willingness to have surgery again (89.6%)
did not change between the 2- and 12-month follow-up times.
Naturally, definition of thresholds relies on the employed external
criterion. Whereas our criterion comprised several aspects of TKA out-
come that we consider important, other authors have used only single
anchor questions [32]. Application of a comprehensive set of questions
as the external criterion for treatment success may well be regarded
as a strength of our study. Patients' expectations are another important
parameter to be considered in TKA [33]. Unfortunately, we did not have
data on whether patients' expectations were met. However, because
this criterion is strongly associated with the single anchors already
used in our study, we would not expect substantial changes in our re-
sults from extending the definition of treatment success in that regard.
We decided to exclude patients who had revision surgery within
12 months after the index procedure, because we believe that early re-
vision (within the first year) is far off target in TKA surgery and cannot
be considered to represent treatment success. We did not want to mix
PRO criteria with objective parameters such as revision, because these
are two fundamentally different. As an example, data from the Swedish
Arthroplasty Register showed that even in patients who had to undergo
revision surgery, more than half were still satisfied with their TKA [34].
The meta-analysis by Janse et al [35] pointed in a similar direction by
highlighting how patients and physicians differ in their assessment of
quality of life. Therefore, we think that from a methodological point of
view, thresholds for PRO measures should rather be based on external
patient-reported criteria.
An interesting approach to investigate validity of the developed
thresholds in this study is a comparison to general population norm
data to find out whether there is a consistent and meaningful associa-
tion to general population distributions. However, general population
norm data are—to the best of our knowledge—not available for the
KSS and scarce for theWOMAC. An Australian study on general popula-
tion norm data for the WOMAC Function scale found a mean of 17.8
points [36], which is comparable to our 12-month threshold of 16.5
points for treatment success. This finding suggests that reaching the
population mean in the WOMAC Function scale reflects treatment suc-
cess. Similarly, the 12-month threshold of 0.80 for the EQ-5D found in
our study is comparable to the Swiss (French-speaking) general popula-
tion mean of 0.83 [37].
The general finding that PRO scales are highly predictive of patient-
reported treatment success following joint arthroplasty is well in line
with other literature [32]. Escobar et al [38] published data on
Fig. 1. ROC curves for WOMAC total (orange), EQ-5D (green), KSS Knee (blue) and KSS Function scores (red) at 2 months (left) and 12 months (right) of follow-up.
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knee arthroplasty by relating the WOMAC scores to various external
criteria including patient satisfaction with symptom state (very or
somewhat satisfied patients were considered positive cases) and a set
of responder criteria used in clinical trials (OMERACT-OARSI criteria
[39] relating to pain, function and global status). The WOMAC scores
in their study also showed good diagnostic accuracy in predicting the
criteria, with an AUC of 0.83 for the pain and function scale. Escobar
et al suggested cut-off scores of 25–29 points for the WOMAC Pain
scale and of 22–27 points for the WOMAC Function scale at 12-month
follow-up (depending on the external criterion) in TKA patients (we
have reversed their scoring for purposes of comparison with our re-
port.) Additional findings were that the cut-off scores in TKA patients
changed less than 5 points among 3-, 6- and 12-month follow-up. How-
ever, baseline scores had amoderate impact on cut-off scores (differences
of up to 15 points), with better baseline scores associated with lower
cut-off scores.
Whereas the study by Escobar et al provides similarfindingswith re-
gard to the WOMAC's ability to predict treatment success, they found
higher cut-off values compared with our study, i.e., higher levels of im-
pairment were still considered a treatment success in their study popu-
lation. This may partly be explained by the different set of external
anchors (i.e., the dichotomization of the satisfaction anchor). We
employed a comprehensive set of four anchor questions that all needed
to be affirmed (this means requiring, for example, more than moderate
treatment satisfaction) to constitute ‘treatment success’. This is a ratherTable 3
Thresholds for Treatment Success and Their Sensitivity and Specificity for theWOMAC, the
EQ-5D and the KSS.
Time Point Optimala Cut-off Sensitivity Specificity
WOMAC Pain 2 months 17.5 0.65 0.75
12 months 7.5 0.83 0.74
WOMAC Stiffness 2 months 31.5 0.76 0.58
12 months 18.5 0.72 0.61
WOMAC Function 2 months 33.5 0.82 0.53
12 months 16.5 0.84 0.67
WOMAC Total 2 months 29.5 0.80 0.57
12 months 16.5 0.85 0.68
EQ-5D 2 months 0.79 0.76 0.67
12 months 0.80 0.70 0.74
KSS Knee Score 2 months 75.5 0.73 0.66
12 months 85.5 0.77 0.72
KSS Function Score 2 months 42.5 0.55 0.63
12 months 72.5 0.59 0.74
a Cut-off with the highest total of sensitivity and specificity.conservative estimate for treatment success; however, the fact that our
thresholds for success are in line with general population norm data
may corroborate our methodological approach. Another portion of the
difference between Escobar et al.'s and our study may be explained by
cross-cultural differences. Unfortunately, our single-center study design
did not allow us to investigate this issue.
Conclusion
We believe that the thresholds presented for theWOMAC score, EQ-
5D and KSS to determine ‘treatment success’ after TKA facilitate inter-
pretation of data from individual patients, study populations or registry
data. Thresholds make abstract score points more tangible and under-
standable in a research context as well as in the daily clinical routine.
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